Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Robin Carroll(National Institutes of Health), Lawrence Corey, Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Alex Hannah(Adaptive Biotechnologies (United States)), Andrew Fioré-Gartland(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nina Marie G. Garcia(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Catherine Yen(National Institutes of Health), Holly Janes(Fred Hutch Cancer Center), Audrey Pettifor(University of North Carolina at Chapel Hill), James E. Stray(Adaptive Biotechnologies (United States)), Koshlan Mayer-Blackwell(Fred Hutch Cancer Center), Jessica Andriesen(Adaptive Biotechnologies (United States)), Moni B. Neradilek(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), April Lo(Adaptive Biotechnologies (United States)), Tracy Qi Dong(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Richard A. Koup, James G. Kublin, Leonid Serebryannyy, Jasmine R Marcelin(University of Nebraska Medical Center), Elizabeth R. Brown, Bob C. Lin(National Institutes of Health)
Cited by 0
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586